Legislation ignores benefits of safe injection sites, say doctors

A leading infection-control expert is urging public health officials to speak out about the benefits of safe injection sites instead of staying silent about new federal legislation that will make it harder for communities across Canada to establish new locations.

“There’s been a lack of leadership across the board, not just from the federal government,” says Dr. Mark Tyndall, chief of the Division of Infectious Diseases at The Ottawa Hospital in Ontario.

“Even local health boards and public health people have not really been vocal in this area. Everybody has just been quite quiet about it, despite overwhelming evidence that this is necessary and that places like Ottawa would greatly benefit from a site like this,” says the University of Ottawa professor.

Laura Eggertson
CMAJ
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below